Palmer B E, Boritz E, Blyveis N, Wilson C C
Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.
J Virol. 2002 Jun;76(12):5925-36. doi: 10.1128/jvi.76.12.5925-5936.2002.
One hallmark of uncontrolled, chronic human immunodeficiency virus type 1 (HIV-1) infection is the absence of strong HIV-1-specific, CD4(+) T-cell-proliferative responses, yet the mechanism underlying this T helper (Th)-cell defect remains controversial. To better understand the impact of HIV-1 replication on Th-cell function, we compared the frequency of CD4(+) Th-cell responses based on production of gamma interferon to lymphoproliferative responses directed against HIV-1 proteins in HIV-1-infected subjects with active in vivo viral replication versus those on suppressed highly active antiretroviral therapy (HAART). No statistically significant differences in the frequencies of cytokine-secreting, HIV-1-specific CD4(+) T cells between the donor groups were found, despite differences in viral load and treatment status. However, HIV-1-specific lymphoproliferative responses were significantly greater in the subjects with HAART suppression than in subjects with active viral replication. Similar levels of HIV-1 RNA were measured in T-cell cultures stimulated with HIV-1 antigens regardless of donor in vivo viral loads, but only HIV-1-specific CD4(+) T cells from subjects with HAART suppression proliferated in vitro, suggesting that HIV-1 replication in vitro does not preclude HIV-1-specific lymphoproliferation. This study demonstrates a discordance between the frequency and proliferative capacity of HIV-1-specific CD4(+) T cells in subjects with ongoing in vivo viral replication and suggests that in vivo HIV-1 replication contributes to the observed defect in HIV-1-specific CD4(+) T-cell proliferation.
未经控制的慢性1型人类免疫缺陷病毒(HIV-1)感染的一个标志是缺乏强烈的HIV-1特异性CD4(+) T细胞增殖反应,然而这种辅助性T细胞(Th细胞)缺陷的潜在机制仍存在争议。为了更好地理解HIV-1复制对Th细胞功能的影响,我们比较了在体内有活跃病毒复制的HIV-1感染受试者与接受高效抗逆转录病毒治疗(HAART)抑制治疗的受试者中,基于γ干扰素产生的CD4(+) Th细胞反应频率与针对HIV-1蛋白的淋巴细胞增殖反应频率。尽管病毒载量和治疗状态存在差异,但在供体组之间未发现细胞因子分泌型HIV-1特异性CD4(+) T细胞频率有统计学显著差异。然而,接受HAART抑制治疗的受试者中HIV-1特异性淋巴细胞增殖反应明显大于有活跃病毒复制的受试者。无论供体体内病毒载量如何,在用HIV-1抗原刺激的T细胞培养物中测量到的HIV-1 RNA水平相似,但只有接受HAART抑制治疗的受试者的HIV-1特异性CD4(+) T细胞在体外增殖,这表明体外HIV-1复制并不排除HIV-1特异性淋巴细胞增殖。这项研究表明,在体内有持续病毒复制的受试者中,HIV-1特异性CD4(+) T细胞的频率和增殖能力之间存在不一致,并表明体内HIV-1复制导致了观察到的HIV-1特异性CD4(+) T细胞增殖缺陷。